FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/14/2022
Back to search
Official data from USPTO
EXPLORNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
EXPLORNA
ST13
US500000079307984Class
5, 42, 44
Filing
79307984
Registration
6756320
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/14/2022
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
01/25/2021
Registration date
06/14/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2022
Last transaction
06/14/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
PL
Examiner
LEE, REBECCA ANN
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
E. O. (pessoa física)
Representatives
Geza Ziegler ZIEGLER IP LAW GROUP LLC.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Human vaccine preparations; vaccine adjuvants; medicinal preparations for the treatment of cancerinfectious diseasesmetabolic diseasesallergic diseasesautoimmune diseasescardiovascular diseasesdiseases of the nervous systemdiseases of gastrointestinal systemdiseases of respiratory systemdiseases of skindiseases of secretory systemsdiseases of bones and jointsdiseases of hematopoietic system and animal diseases; nucleic acid sequences and chemical reagents for medical and veterinary purposes
Class 42
Research and development of mRNA therapeutics; biochemical research and development; research and development of vaccines and medicines; pharmaceutical products development; testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; working on and evaluation of chemical syntheses
Class 44
Medical analysis for the diagnosis and treatment of persons; Medical analysis services in the nature of RNA or DNA analysis for the diagnosis and prognosis of cancer; consultancy services relating to health care; medical services in the fields of oncologydentistryophthalmologytransplant medicineinfectious diseasesmetabolic diseasesallergic diseasesautoimmune diseasescardiovascular diseasesdiseases of the nervous systemdiseases of gastrointestinal systemdiseases of respiratory systemdiseases of skindiseases of secretory systemsdiseases of bones and jointsdiseases of hematopoietic system
Publications
History of USPTO decisions and trademark events.
33 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/06/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
10/06/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/14/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/27/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/29/2022
PUBO
PUBLISHED FOR OPPOSITION
03/29/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/27/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/10/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/09/2022
ALIE
ASSIGNED TO LIE
02/22/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/22/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/21/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/20/2022
GNFR
FINAL REFUSAL E-MAILED
02/20/2022
CNFR
FINAL REFUSAL WRITTEN
02/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/28/2022
RFNT
REFUSAL PROCESSED BY IB
10/25/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/30/2021
RFRR
REFUSAL PROCESSED BY MPU
09/30/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/16/2021
CNRT
NON-FINAL ACTION WRITTEN
09/15/2021
DOCK
ASSIGNED TO EXAMINER
08/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
04/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/01/2021
Continuous trademark protection
Get notified about every new filing that threatens EXPLORNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.